SCHEMBL5635191

SCHEMBL5635191

Cc1ccccc1Nc1ncc(C(=O)c2ccccc2C(F)(F)F)s1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.56
MAPK12 P53778 10/20 0.56
MAPK11 Q15759 10/20 0.56
MAPK14 Q16539 10/20 0.56
HTT P42858 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PLA2G1B P04054 1/20 0.48
MAPT P10636 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634604 0.88 MAPK13 (0.59) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634110 0.86 MAPK13 (0.67) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634397 0.83 MAPK13 (0.74) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634502 0.82 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634240 0.81 MAPK13 (0.53) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5635186 0.81 NPC1 (0.64) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL27607828 0.81 RAB9A (0.46) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634355 0.80 NPC1 (0.72) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5635687 0.80 MAPK13 (0.51) MAPK13MAPK12MAPK11MAPK14HTT
SCHEMBL5634748 0.77 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253197-B2 Aminothiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2007-08-07 US disclosed
EP-1539722-A1 THIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-15 EP disclosed
US-20040038990-A1 Aminothiazole derivatives HOFFMANN-LA ROCHE INC. 2004-02-26 US disclosed
WO-2004014884-A1 THIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038990-A1 Aminothiazole derivatives FABP4, GPR119, ABAT MAPK13 3018/4885MAPK12 2608/4885MAPK11 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.